Functional remodeling of macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma

被引：0
|
作者：
Han, Zhen [1 ,5 ]
Su, Ching-Yu [1 ,5 ]
Wu, Xiwei [2 ,5 ]
Qin, Hanjun [2 ,5 ]
Zain, Jasmine [3 ]
Rosen, Steven T. [3 ,5 ]
Querfeld, Christiane [1 ,3 ,4 ,5 ]
机构：
[1] City Hope Natl Med Ctr, Div Dermatol, Duarte, CA USA
[2] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Duarte, CA USA
[3] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[4] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA
[5] Beckman Res Inst, Duarte, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 156卷
关键词：
Tumor microenvironment; PD1/PD-L1; blockade; lenalidomide; macrophage remodeling; CTCL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prec-O2-04
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [21] IMMUNOTHERAPY Benefit with anti-PD-L1
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (02) : 70 - 70
  • [22] Anti-PD-L1 chimeric antigen receptor natural killer cell: Characterization and functional analysis
    Yazdanpanah-Samani, Mahsa
    Ramezani, Amin
    Sheikhi, Abdolkarim
    Mostafavi-Pour, Zohreh
    Erfani, Nasrollah
    APMIS, 2024, 132 (12) : 1115 - 1127
  • [23] Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy
    Chen, Hu
    Zhang, Pengfei
    Shi, Yesi
    Liu, Chao
    Zhou, Qianqian
    Zeng, Yun
    Cheng, Hongwei
    Dai, Qixuan
    Gao, Xing
    Wang, Xiaoyong
    Liu, Gang
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [24] Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy
    Hu Chen
    Pengfei Zhang
    Yesi Shi
    Chao Liu
    Qianqian Zhou
    Yun Zeng
    Hongwei Cheng
    Qixuan Dai
    Xing Gao
    Xiaoyong Wang
    Gang Liu
    Journal of Nanobiotechnology, 20
  • [25] Effect of NK cell treatment on PD-L1 expression and anti-PD-L1 response
    Copik, Alicja
    Oyer, Jeremiah
    Gitto, Sarah
    Altomare, Deborah
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [26] MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells
    Zhong Zheng
    Rui Sun
    Hui-Jin Zhao
    Di Fu
    Hui-Juan Zhong
    Xiang-Qin Weng
    Bin Qu
    Yan Zhao
    Li Wang
    Wei-Li Zhao
    Molecular Cancer, 18
  • [27] MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells
    Zheng, Zhong
    Sun, Rui
    Zhao, Hui-Jin
    Fu, Di
    Zhong, Hui-Juan
    Weng, Xiang-Qin
    Qu, Bin
    Zhao, Yan
    Wang, Li
    Zhao, Wei-Li
    MOLECULAR CANCER, 2019, 18 (1)
  • [28] Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies
    Philips, George K.
    Atkins, Michael
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (01) : 39 - 46
  • [29] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
  • [30] The regulation of PD-L1 expression by miRNAs in cutaneous T-cell lymphoma
    Querfeld, Christiane
    Estephan, Renee
    Kil, Sung Hee
    Rosen, Steven T.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : S9 - S9
12345